FLXN - Flexion Therapeutics Inc
Close
9.12
-0.020 -0.219%
Share volume: 0
Last Updated: Thu 18 Nov 2021 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$9.14
-0.02
-0.22%
Summary score
42%
Profitability
47%
Dept financing
23%
Liquidity
47%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2017 - 30-Jun-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
15.01%
Return on assets
-11.23%
Return on sales
-1251.99%
Return on invested capital
199.52%
Total debt ratio
83.43%
Debt ratio change over timeo
-0.54%
Current Ratio
7.82%
Quick Ratio
7.19%
Cash Position Ratio
6.5%
Short-term ratios 30-Jun-2020 - 30-Jun-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
256.75%
Return on assets
-7.73%
Return on sales
-72.03%
Return on invested capital
103.71%
Total debt ratio
112.85%
Debt ratio change over timeo
-0.16%
Current Ratio
4.22%
Quick Ratio
3.96%
Cash Position Ratio
3.19%
Last quarter ratios 30-Jun-2021
The data are presented for the financials results of the last quarter.
Return on equity
39.54%
Return on assets
-8.04%
Return on sales
-59.92%
Return on invested capital
158.57%
Total debt ratio
126.74%
Debt ratio change over time
-0.2%
Current Ratio
4.61%
Quick Ratio
4.3%
Cash Position Ratio
3.29%
Performance ratios (change over 4 years) 30-Jun-2017 - 30-Jun-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-50.21%
Return on assets
-105.7%
Return on sales
-448.59%
Return on invested capital
9.09%
Total debt ratio
-53.65%
Debt ratio change over time
-0.54%
Current Ratio
2.73%
Quick Ratio
2.6%
Cash Position Ratio
2.12%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FLXN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 15.01% | 0% | 0% | 22.62% |
| Return on assets | -11.23% | 0% | 0% | -9.75% |
| Return on sales | -1251.99% | 0% | 0% | -2017.42% |
| Return on invested capital | 199.52% | 0% | 0% | 66.76% |
| Profitability | 42% | 0% | 50% | 33% |
| Total debt ratio | 83.43% | 0% | 0% | 108.98% |
| Debt ratio change over time | -0.54% | 0% | 0% | -0.65% |
| Dept financing | 19% | 0% | 25% | 25% |
| Current Ratio | 4.22% | 0% | 0% | 8.37% |
| Quick Ratio | 3.96% | 0% | 0% | 8.37% |
| Cash Position Ratio | 3.19% | 0% | 0% | 8.07% |
| Liquididy | 75% | 0% | 0% | 59% |
| Short-term ratios | FLXN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 256.75% | 0% | 0% | -23.1% |
| Return on assets | -7.73% | 0% | 0% | -7.41% |
| Return on sales | -72.03% | 0% | 0% | -3524.38% |
| Return on invested capital | 103.71% | 0% | 0% | 87.65% |
| Profitability | 50% | 0% | 50% | 21% |
| Total debt ratio | 112.85% | 0% | 0% | 58.83% |
| Debt ratio change over time | -0.16% | 0% | 0% | 0.08% |
| Dept financing | 25% | 0% | 0% | 38% |
| Current Ratio | 4.22% | 0% | 0% | 8.37% |
| Quick Ratio | 3.96% | 0% | 0% | 8.37% |
| Cash Position Ratio | 3.19% | 0% | 0% | 8.07% |
| Liquididy | 34% | 0% | 0% | 75% |